v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Feb. 28, 2025
Feb. 29, 2024
Feb. 28, 2023
Cash provided by operating activities:      
Net income $ 123,751 $ 168,594 $ 143,273
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 55,048 51,499 44,683
Amortization of financing costs 1,265 1,235 1,114
Non-cash operating lease expense 11,100 10,191 9,702
Provision for credit losses (143) 6,103 1,798
Non-cash share-based compensation 21,376 33,872 26,753
Non-cash restructuring charges 0 1,772 0
Asset impairment charges 51,455 0 0
Loss on extinguishment of debt 0 489 0
Gain on sale of distribution and office facilities 0 (34,190) 0
Gain on sale of Personal Care business 0 0 (1,336)
(Gain) loss on the sale or disposal of property and equipment (32) (233) 63
Deferred income taxes and tax credits (75,982) 13,210 (2,242)
Changes in operating capital, net of effects of acquisition of businesses:      
Receivables (23,080) (18,668) 83,624
Inventory (40,599) 58,192 110,304
Prepaid expenses and other current assets 4,351 (2,405) 2,778
Other assets and liabilities, net 546 (2,830) (355)
Accounts payable 20,459 54,403 (115,931)
Accrued expenses and other current liabilities (40,227) (36,287) (88,040)
Accrued income taxes 3,925 1,120 (7,946)
Net cash provided by operating activities 113,213 306,067 208,242
Cash (used) provided by investing activities:      
Capital and intangible asset expenditures (30,072) (36,644) (174,864)
Net payments to acquire businesses, net of cash acquired (229,428) 0 (146,342)
Payments for purchases of U.S. Treasury Bills (4,531) (9,605) 0
Proceeds from maturity of U.S. Treasury Bills 2,508 622 0
Proceeds from sale of distribution and office facilities 0 49,456 0
Proceeds from sale of Personal Care business 0 0 1,804
Proceeds from the sale of property and equipment 180 1,620 69
Payment for promissory note (1,750) 0 0
Net cash (used) provided by investing activities (263,093) 5,449 (319,333)
Cash provided (used) by financing activities:      
Proceeds from revolving loans 1,096,610 1,415,511 685,800
Repayment of revolving loans (840,460) (1,686,580) (795,300)
Proceeds from term loans 0 248,868 250,000
Repayment of long-term debt (6,250) (246,875) (19,832)
Payment of financing costs (345) (2,025) (586)
Proceeds from share issuances under share-based compensation plans 3,879 4,235 5,066
Payments for repurchases of common stock (103,188) (55,222) (18,365)
Net cash provided (used) by financing activities 150,246 (322,088) 106,783
Net cash provided (used) by financing activities 366 (10,572) (4,308)
Cash and cash equivalents, beginning balance 18,501 29,073 33,381
Cash and cash equivalents, ending balance 18,867 18,501 29,073
Supplemental cash flow information:      
Interest paid 50,154 52,537 43,687
Income taxes paid, net of refunds 40,843 28,855 37,082
Supplemental non-cash investing activity:      
Capital expenditures included in accounts payable and accrued expenses $ 6,755 $ 7,491 $ 5,847